» Articles » PMID: 21951566

Validity and Reliability of the TED-QOL: a New Three-item Questionnaire to Assess Quality of Life in Thyroid Eye Disease

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 2011 Sep 29
PMID 21951566
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To develop and test a user-friendly questionnaire for rapidly assessing quality of life (QOL) in thyroid eye disease (TED).

Methods: A three-item questionnaire, the TED-QOL, was designed and compared to the 16-item Graves Ophthalmopathy (GO)-QOL and the nine-item GO-Quality of Life Scale (QLS). 100 patients with TED were administered all three questionnaires on two occasions. Results were compared to clinical severity scores (Vision, Inflammation, Strabismus, Appearance (VISA) classification). Main outcomes were construct and criterion validity, test-retest reliability, duration, comprehension and completion rates. TED-QOL correlated strongly with the other questionnaires for corresponding items (Pearson correlation: appearance 0.71, 0.62; functioning 0.69, 0.66; overall QOL 0.53). Test-retest analysis demonstrated good reliability for all three questionnaires (intraclass correlations: TED-QOL 0.81, 0.74, 0.87; GO-QOL 0.81, 0.82; GO-QLS 0.74, 0.86, 0.67). TED-QOL was significantly faster to complete (1.6 min vs GO-QOL 3.1 min, GO-QLS 2.7 min, p<0.0001) and had a higher completion rate (100% vs GO-QOL 78%, GO-QLS 94%). There was only moderate correlation between items on all three questionnaires and VISA scores.

Conclusion: The TED-QOL is rapid and easy to complete and analyse and has similar validity and reliability to longer questionnaires. All questionnaires showed only moderate correlation with disease severity, emphasising the discrepancy between objective and subjective assessments and the importance of measuring both.

Citing Articles

Quality of life in patients with Graves' orbitopathy submitted to orbital decompression: comparison between balanced and inferomedial techniques.

Leite C, Pereira T, Chiang J, Moritz R, Goncalves A, Monteiro M Arq Bras Oftalmol. 2024; 87(5):e20230296.

PMID: 39109703 PMC: 11627165. DOI: 10.5935/0004-2749.2023-0296.


How patients experience thyroid eye disease.

Smith T, Hegedus L, Lesser I, Perros P, Dorris K, Kinrade M Front Endocrinol (Lausanne). 2023; 14:1283374.

PMID: 38027128 PMC: 10665908. DOI: 10.3389/fendo.2023.1283374.


TSH receptor autoantibody levels post-total thyroidectomy in Graves' ophthalmopathy: a meta-analysis.

Anees A, Ayeni F, Eslick G, Edirimanne S Langenbecks Arch Surg. 2023; 408(1):415.

PMID: 37870639 PMC: 10593610. DOI: 10.1007/s00423-023-03153-3.


Strabismus surgery for improving the quality of life of strabismus patients with thyroid-associated ophthalmopathy.

Huang Y, Li K, Yan Y, He J, Chen J Medicine (Baltimore). 2023; 102(35):e34778.

PMID: 37657062 PMC: 10476816. DOI: 10.1097/MD.0000000000034778.


Facial expression of patients with Graves' orbitopathy.

Lei C, Qu M, Sun H, Huang J, Song X, Zhai G J Endocrinol Invest. 2023; 46(10):2055-2066.

PMID: 37005981 DOI: 10.1007/s40618-023-02054-y.